Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-02-16 4:20 pm Sale | 13G | Constellation Pharmaceuticals, Inc. CNST | THIRD ROCK VENTURES LP | 164,190 0.3% | -2,869,893 (-94.59%) | View |
| 2020-02-05 4:36 pm Sale | 13G | Rhythm Pharmaceuticals, Inc. RYTM | THIRD ROCK VENTURES LP | 323,526 0.7% | -2,757,016 (-89.50%) | View |
| 2019-02-13 4:09 pm Sale | 13G | Kala Pharmaceuticals, Inc. KALA | THIRD ROCK VENTURES LP | 119,871 0.4% | -1,542,114 (-92.79%) | View |
| 2019-02-13 4:07 pm Sale | 13G | CytomX Therapeutics, Inc. CTMX | THIRD ROCK VENTURES LP | 227,653 0.5% | -3,237,981 (-93.43%) | View |
| 2019-02-13 4:06 pm Sale | 13G | Rhythm Pharmaceuticals, Inc. RYTM | THIRD ROCK VENTURES LP | 3,080,542 9% | -900,895 (-22.63%) | View |
| 2019-02-13 4:03 pm Purchase | 13G | Constellation Pharmaceuticals, Inc. CNST | THIRD ROCK VENTURES LP | 3,034,083 11.8% | 3,034,083 (New Position) | View |